Up 15% today, check out the stock doctor's review.
http://client.lincolnindicators.com.au/sg_current/index.html
http://client.lincolnindicators.com.au/sg_current/index.html
Up 15% today, check out the stock doctor's review.
http://client.lincolnindicators.com.au/sg_current/index.html
Another super stars on the rise
watch out folks ...
this one is small but command nice monopoly due to patents
my valueation is around 10c
Once cent dividend coming in October ...
Revenue strong
Very nice Margin increase
Economy of Scale
Strategic Investment in a Canadian start up
time to slowly move to mid-cap
I took up equity raising, bought more during recent panic ...all add up to a nice dividend cheque this year...
ROE, what do you make of note 9. Specifically the increase in past due accounts from $600k to $1.5m. The note says they relate to a "number of independant customers" but don't give much more detail.
I haven't been paying attention where do you see this?
Probably someone forgot to pay their bills see if this figure grow or decline in the next
few reports ... could be a once off thing ...be alert but don't be alarm.
Still kick myself for not getting in on these guys around 10c.
Just had a quick look at their reports and am i right they aren't paying a dividend any more? Or do they only pay one once a year?
Still kick myself for not getting in on these guys around 10c.
Ditto here.
I've long harboured the theory that CPB will eventually bid for and take over XRF although maybe it's too small at this stage for CPB to notice them! CPB have a history of growth by acquisition although XRF would be more of a supplier to them rather than a competitor.
Any comments on this?
Looks like XRF is back on track to a path of steady growth..
Assuming the second half is slightly better than the first (as management have hinted at) we could see XRF breaking the 30c mark..
Hello and welcome to Aussie Stock Forums!
To gain full access you must register. Registration is free and takes only a few seconds to complete.
Already a member? Log in here.